In this time of uncertainty and turmoil, the goal of bringing new treatments to market is paramount. hyperCORE International is working with Sponsors and CROs to make this a reality at a time when it is needed the most. As one of the largest, most collaborative site networks in the world, we understand that the most important functions of today’s landscape is rapid start-up and execution of potential and current trials.
Experience and Quality...Streamlined
10,000+ COVID-19 Tests AdministeredPer Week
5,000+ Patients a Month for TreatmentStudies (Outpatient)
1 Million+ Overall Patient Availability 100,000+ Patients Enrolled in VaccineTrials.
Experience in 40+ Infectious Disease Indications
1,100+ Respiratory Trials Completed(Including Severe Pneumonia)